Skip to main content
Premium Trial:

Request an Annual Quote

Peter Luk

Gyros Protein Technologies has named Peter Luk VP, Asia-Pacific. 

Luk brings the Swedish immunoassay and peptide chemistry firm more than 25 years of experience in Asia. He last served as General Manager for Asia at ProteinSimple. Prior to that, he served as VP, Asia-Pacific for Molecular Devices. He has also worked for PerkinElmer, Packard Biosciences, and Bio-Rad Laboratories. 

Luk holds an undergraduate degree from the University of Leeds in the UK and an MBA from City University of Hong Kong.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.